Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy
NCT03649529
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Melanoma
Interventions
BIOLOGICAL:
GPA-TriMAR-T
Sponsor
Timmune Biotech Inc.
Collaborators
[object Object]
[object Object]